Clinical trial
A Study of Abatacept in Patients With Active Ulcerative Colitis
NCT00410410 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00410410 |
|---|---|
| Title | A Study of Abatacept in Patients With Active Ulcerative Colitis |
| Official title | A Phase 3, Multi-Center, Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With Abatacept in Subjects With Active Ulcerative Colitis (UC) Who Have Had an Inadequate Clinical Response and/or Intolerance to Medical Therapy |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Ulcerative Colitis |
| Intervention type | Drug |
| Interventions | abatacept (ABA), placebo, abatacept |
| Enrollment | 591 |
| Start date | Dec 1, 2006 |
| Primary completion | Jun 1, 2009 |
| Completion | Nov 1, 2009 |
| First posted | Dec 12, 2006 |
| Last update posted | Mar 24, 2015 |
| Countries | Australia, Belgium, Brazil, Canada, Czechia, France, Germany, India, Ireland, Italy, Mexico, Netherlands and 7 more |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: